Literature DB >> 2835513

Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins.

S A Jenison1, J M Firzlaff, A Langenberg, D A Galloway.   

Abstract

Human papillomavirus (HPVs) infect the genital epithelium and are found in proliferative lesions ranging from benign condylomata to invasive carcinomas. The immunological response to these infections is poorly understood because of the lack of purified viral antigens. In this study, bacterially derived fusion proteins expressing segments of all the major open reading frames (ORFs) of HPV type 6b (HPV-6b) have been used in Western blot (immunoblot) assays to detect antibodies directed against HPV-encoded proteins. The most striking reactivities present in sera from patients with genital warts were to the HPV-6b L1 ORF protein and, to a lesser extent, to the HPV-6b L2 ORF protein. Two cases of reactivity to HPV-6b E2 ORF were observed, but no reactivities were seen with other HPV-6b constructs. Two sera reacted with the HPV-16 L2 fusion protein, and two sera reacted with the HPV-16 E4 protein. The antibodies directed against the HPV-6b fusion proteins showed no cross-reactivity with comparable regions of the HPV-16 ORFs. This assay provides a useful approach for further studies of HPV serology.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835513      PMCID: PMC253307          DOI: 10.1128/JVI.62.6.2115-2123.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Wart-associated antigens. II. Human immunity to viral structural proteins.

Authors:  F Pass; J V Maizel
Journal:  J Invest Dermatol       Date:  1973-05       Impact factor: 8.551

2.  Evidence for antigenic determinants shared by the structural polypeptides of (Shope) rabbit papillomavirus and human papillomavirus type 1.

Authors:  G Orth; F Breitburd; M Favre
Journal:  Virology       Date:  1978-12       Impact factor: 3.616

3.  Regression of warts. An immunological study.

Authors:  S Pyrhönen; E Johansson
Journal:  Lancet       Date:  1975-03-15       Impact factor: 79.321

4.  Immune reactions in epidermodysplasia verruciformis.

Authors:  S Pyrhönen; S Jablonska; S Obałek; E Kuismanen
Journal:  Br J Dermatol       Date:  1980-03       Impact factor: 9.302

5.  A quantitative micro-complement fixation method in studies of human wart viruses.

Authors:  J M Hefton; M Eisinger
Journal:  J Gen Virol       Date:  1978-01       Impact factor: 3.891

6.  Seroepidemiologic studies of bovine papillomavirus infections.

Authors:  H Pfister; B Huchthausen; G Gross; H zur Hausen
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

7.  Characterization of a new type of human papillomavirus that causes skin warts.

Authors:  G Orth; M Favre; O Croissant
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

8.  Immunologic relatedness of papillomaviruses from different species.

Authors:  A B Jenson; J D Rosenthal; C Olson; F Pass; W D Lancaster; K Shah
Journal:  J Natl Cancer Inst       Date:  1980-03       Impact factor: 13.506

9.  Hunan wart-virus antibodies in patients with genital and skin warts.

Authors:  S Pyrhönen
Journal:  Acta Derm Venereol       Date:  1978       Impact factor: 4.437

10.  Identification of an immunologically distinct papillomavirus from lesions of epidermodysplasia verruciformis.

Authors:  F Pass; M Reissig; K V Shah; M Eisinger; G Orth
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

View more
  28 in total

1.  Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro.

Authors:  S M Horikami; J Curran; D Kolakofsky; S A Moyer
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.

Authors:  C Bleul; M Müller; R Frank; H Gausepohl; U Koldovsky; H N Mgaya; J Luande; M Pawlita; J ter Meulen; R Viscidi
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

Review 3.  Multiplicity of uses of monoclonal antibodies that define papillomavirus linear immunodominant epitopes.

Authors:  A B Jenson; M C Jenson; L Cowsert; S J Ghim; J P Sundberg
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

4.  Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies.

Authors:  Joshua W Wang; Subhashini Jagu; Wai-Hong Wu; Raphael P Viscidi; Anne Macgregor-Das; Jessica M Fogel; Kihyuck Kwak; Sai Daayana; Henry Kitchener; Peter L Stern; Patti E Gravitt; Cornelia L Trimble; Richard B S Roden
Journal:  Clin Vaccine Immunol       Date:  2015-05-13

5.  Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope.

Authors:  S A Jenison; X P Yu; J M Valentine; D A Galloway
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

6.  Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodies.

Authors:  D E Goade; R Bell; T Yamada; G J Mertz; S Jenison
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

7.  Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions.

Authors:  N Yaegashi; S A Jenison; J M Valentine; M Dunn; L B Taichman; D A Baker; D A Galloway
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

Review 8.  Pathogenesis of genital HPV infection.

Authors:  A Schneider
Journal:  Genitourin Med       Date:  1993-06

Review 9.  Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis.

Authors:  C P Crum; S Barber; J K Roche
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

10.  Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata.

Authors:  A Wikström; C Eklund; G Von Krogh; P Lidbrink; J Dillner
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.